The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

The following summary describes the peer review process for this journal ... The cost for open access publication in Gene Therapy is £3,190/ $4,790/ €3,690 (VAT or local taxes will be ...

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side effect experienced by one participant on a high dose of its Rett therapy.

Sangamo said it plans to explore all options to commercialise the asset, including seeking a potential new collaboration partner.

The $34m seed round was led by Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital. Credit: Gorodenkoff via Shutterstock. US-based gene therapy startup, GEMMABio has raised ...

Discover promising gene therapy results from Tenaya Therapeutics, Inc.'s TN-201 and TN-401 projects, potential impact on ...